11:30 AM SIGN-IN & LUNCH • 12:00 PM - 1:30 PM

BANDOL 1 (NEW WYNN SPACE)

CE: Chronic Inflammatory Demyelinating Polyneuropathy: Assessing the Application of Intravenous and Subcutaneous Immunoglobulin, Featuring a Patient Perspective

Chronic inflammatory demyelinating polyneuropathy is a rare, debilitating, and degenerative neurologic illness characterized by progressive weakness due to peripheral nerve damage. Inflammation of nerve roots and peripheral nerves results in myelin sheath destruction and subsequent impairment of motor and sensory functioning of extremities. If left untreated, an estimated 30% of patients would eventually become wheelchair dependent. Current treatment options provide symptomatic improvement and include corticosteroids, immunosuppressive agents, intravenous and subcutaneous immunoglobulin, and plasma exchange. This activity will provide an overview of CIDP, including a discussion on the burden of illness on patient quality of life and economic effect due to health care usage, focus on the intricacies of CIDP management, and implications for specialty pharmacy. The presentation will include an interview with a patient describing his journey living with CIDP, navigating treatment, and experiences in interacting with pharmacists.

Speakers

Jonathan Ogurchak

Gil Wolfe

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
2021Summit_Logo_White.png